Hepatic-specific knockdown of MFN2 in mice causes inflammation, triglyceride accumulation, fibrosis, and hepatocellular carcinoma; however, re-expression in a mouse model of NASH ameliorates these conditions [639], highlighting the beneficial role played by MFN2 in NAFLD. The gene discussed is MFN2; the disease is metabolic dysfunction-associated steatotic liver disease.